Endoscopic findings, Helicobacter pylori status, and dyspeptic complaints in vagotomized or medically treated peptic ulcer patients and healthy community controls

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 5, 1999, Pages 465-470

  Lindsetmo, Rolv Ole ^a   Johnsen, R ^a   Revhaug, A ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Dyspepsia; Endoscopic findings; Follow up; Helicobacter pylori; Vagotomy

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DUODENITIS; DYSPEPSIA; ESOPHAGITIS; FEMALE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; VAGOTOMY;

EID: 0033059517     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655299750026173     Document Type: Article

References (40)

1. Forman D. The prevalence of Helicobacter pylori infection in gastric cancer. Aliment Pharmacol Ther 1995;9 Suppl 2:71-6.
2. The Eurogast study group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62.
3. Kuipers EJ, Lundell L, Klinkenberg-Knohl EC, Havu N, Festen HPM, Liedman B, et al. Atrophic changes and Helicobacter pylori infection in patients with reflux esohagitis treated with omeprazole or fundoplication. N Engl J Med 1996;1334:1118-22.
4. Kuipers FJ, Uyterlinde AM, Pena AS, Hazenberg HJA, Bloemena E, Lindeman J, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: Implications for long-term safety. Am J Gastroenterol 1995;90:1401-6.
5. European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41:8-13.
6. Modlin JM, Goldenring JR, Lawton GP, Hunt R. Clinical review. Aspects of the theoretical and clinical relevance of low acid states. Am J Gastrenterol 1994;89:308-18.
7. Johnsen R, Bernersen B, Straume B, Førde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. Br Med J 1991;302:749-52.
8. Earlam RJ, Amerigo J, Kakavoulis T, Pollock DJ. Histological appearances of oesophagus, antrum and duodenum and their correlation with symptoms in patients with a duodenal ulcer. Gut 1985;26:95-100.
9. Bytzer P, Møller Hansen J, Havelund T, Malchow-Møller A, Scaffalitzky de Muckadell OB. Predicting endoscopic diagnosis in the dyspeptic patients: the value of clinical judgement. Eur J Gastroenterol Hepatol 1996;8:359-63.
10. Boutet R. GPs are already choosing eradication therapy over endoscopy. Br Med J 1998;316:1388-9.
11. Bernersen B, Johnsen R, Straume B. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut 1996;38:822-5.
12. Eypasch E, Triodl H, Wood-Dauphinée S, Williams JI, Reinecke K, Ure B, et al. Quality of life and gastrointestinal surgery - a clinimetric approach to developing an instrument for its measurement. Theor Surg 1990;5:3-10.
13. Revill SI, Robinson JO, Rosen M, Hogg MIJ. The reliability of a linear analogue for evaluating pain. Anaesthesia 1976;31:1191-8.
14. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991;6:209-22.
15. Savary M, Miller G. Der Esophagus. Lehrbuch und endoscopischer Atlas. Soloturn: Gassmann; 1977.
16. Valentine JL, Arthur RR, Mobley HLT, Dick JD. Detection of Helicobacter pylori by using the polymerase chain reaction. J Clin Microbiol 1991;29:689-95.
17. Tee W, Fairley S, Smallwood R, Dwyer B. Comparative evaluation of three selective media and a non-selective medium for the culture of Helicobacter pylori from gastric biopsies. J Clin Microbiol 1991;29:2587-9.
18. Marshall BJ, Warren JR, Francis GJ, Langton SR, Goodwin CS, Blinlow ED. Rapid urease test in the management of Campylobacter pyloridis associated gastritis. Am J Gastroenterol 1987;82:200-10.
19. Berstad K, Wilhelmsen K, Berstad A. Biometric evaluation of gastric urease activity in man. Scand J Gastroenterol 1992;27:977-83.
20. van de Wouw BAM, de Boer WA, Janzl AR, Roymans RTJM, Staals APG. Comparison of three commercially available enzyme-linked immunosorbent assays and biopsy-dependent diagnosis for detecting Helicobacter pylori infection. J Clin Microbiol 1996;34:94-7.
21. Feldman RA, Evans SJW. Accuracy of diagnostic methods used for epidemiological studies of Helicobacter pylori. Aliment Pharmacol Ther 1995;9 Suppl 2:21-31.
22. Gardner MJ, Gardner SB, Winter PD Confidence intervals analysis. London: BMJ Publishing Group; 1992.
23. Dean AG, Dean FA, Burton AH, Dicker RC Epi Info, version 6: a word processing, database and statistics system for epidemiology on microcomputers. Stone Mountain (GA): USD; 1994.
24. Bernersen B, Johnsen R, Bostad L, Straume B, Sommer AI, Burhol PG. Is Helicobacter pylori the cause of dyspepsia? Br Med J 1992;304:1276-9.
25. Ihamäki T, Kekki M, Sipponen P, Siurala M. The sequela and course of chronic gastritis during a 30 to 34 year bioptic follow-up study. Scand J Gastroenterol 1985;20:485-91.
26. McCloy RF, Arnold R, Barnhan KD, Cattan D, Klinkenberg-Knol E, Maton PN, et al. Pathophysiological effects of long-term acid suppression in man. Dig Dis Sci 1995;40 Suppl 2:96120.
27. Ditlefsen S. Survival after vagotomy: results of the Aarhus County Vagotomy trial. World J Surg 1989;13:776-80.
28. Caygill CP, Hill MJ, Kirkham JS, Northfield TC. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet 1986;1:929-31.
29. Lundegardh G, Ekbom A, McLaughlin JK, Nyren O. Gastric cancer risk after vagotomy. Gut 1994;35:946-9.
30. Fisher SG, Davis F, Nelson R, Weber L, Goldberg J, Haenszel W. A cohort study of stomach cancer risk in men after gastric ulcer surgery for benign disease. J Natl Cancer Inst 1993;85:1303-10.
31. Lind T, Cederberg C, Olausson M, Olbe L. 24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients. Gastroenterology 1990;99:1593-8.
32. Johnson JA, Giercksky KE. Proximal gastric vagotomy and ulcerectomy for gastric ulcer. Tidsskr Nor Laegeforen 1987;107:1121-3.
33. Hyvarinen H, Seppala K, Anisimova S, Kabri A, Kivilaakso E, Palmu A. Relation between ulcer recurrence 9-18 years after proximal gastric vagotomy for duodenal ulcer to H. pylori infection and acid secretion. Am J Gastroenterol 1994;89(A451):1398.
34. Figura N. Helicobacter pylori exotoxins and gastroduodenal disease associated with cytotoxic strain infection. Aliment Pharmacol Ther 1996;10 Suppl 1:79-96.
35. Crabtree JE. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 1996;10 Suppl 1:29-37.
36. Blaser MJ. Ecology of Helicobacter pylori in the human stomach. J Clin Invest 1997;100:759-62.
37. Tytgat GN. The Sydney System: endoscopic division. Endoscopic appearances in gastritis/duodenitis. J Gastroenterol Hepatol 1991;6:223-34.
38. Lindsetmo R-O, Johnsen R, Revhaug A. Abdominal and dyspeptic symptoms in patients with peptic ulcer treated medically or surgically. Br J Surg 1998;85:845-9.
39. Pettersen H, Kristensen P, Johannessen T, Kleveland M, Dybdahl JH, Myrvold H. The natural course of peptic ulcer disease and its predictors. Scand J Gastroenterol 1995;30:17-24.
40. NIH Consensus Conference. Helicobacter pylori in the peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.